| Print
XBiotech (XBIT)
Common SharesThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP
Company profile
XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
Address
8201 E. Riverside Drive
Building 4, Suite 100
Austin
TX
CAN
78744
Telephone
+1 512 3862993
Forecast key dates
| Name | Key Date |
|---|---|
| XBiotech Inc Annual Report for 2026 | 2027-03-12T00:00:00 |
| XBiotech Inc Third Quarter Earnings Results for 2026 | 2026-11-12T00:00:00 |
| XBiotech Inc Second Quarter Earnings Results for 2026 | 2026-08-13T00:00:00 |
| XBiotech Inc Annual General Meeting for 2026 | 2026-06-19T10:00:00 |
| XBiotech Inc First Quarter Earnings Results for 2026 | 2026-05-14T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| XBiotech Inc Annual Report for 2025 | 2026-03-13T00:00:00 |
| XBiotech Inc Third Quarter Earnings Results for 2025 | 2025-11-12T00:00:00 |
| XBiotech Inc Second Quarter Earnings Results for 2025 | 2025-08-13T00:00:00 |
| XBiotech Inc Annual General Meeting for 2025 | 2025-06-20T10:00:00 |
| XBiotech Inc First Quarter Earnings Results for 2025 | 2025-05-14T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2026 AJ Bell. All rights reserved.